Team:EPF-Lausanne/Our Project/TetR mutants/Conclusion

From 2011.igem.org

(Difference between revisions)
Line 47: Line 47:
| normal
| normal
|}
|}
 +
 +
 +
The P39K mutant shows in both cases (''in vivo'' and ''in vitro'') no affinity to the Ptet consensus sequence, showing that our results are consistent between the two characterizations. The V36F mutant either shows a stronger or a similar binding affinity compared to the WT. Finally, the E37A W43S T141A triple mutant either has the same or an altered binding affinity.
 +
 +
The results coming from the ''in vivo'' and ''in vitro'' part are effectively related, albeit incompletely. We have tested only 3 mutants in both systems ; we would need more characterization results to improve our selection systems, especially the ''in vivo'' part.
The MITOMI results can be found [https://2011.igem.org/Team:EPF-Lausanne/Our_Project/TetR_mutants/MITOMI_data here]. The in vivo characterizations are on [https://2011.igem.org/Team:EPF-Lausanne/Our_Project/Reporter_Systems/tetR#TetR_mutant_characterization this page].
The MITOMI results can be found [https://2011.igem.org/Team:EPF-Lausanne/Our_Project/TetR_mutants/MITOMI_data here]. The in vivo characterizations are on [https://2011.igem.org/Team:EPF-Lausanne/Our_Project/Reporter_Systems/tetR#TetR_mutant_characterization this page].

Revision as of 03:50, 22 September 2011